Now livetag icon
The official Gen AI Landscape report for 2026 is here. Don’t miss out!Get your copybanner icon
Empirico

July 2026

Empirico Market Share Analysis for July 2026

Help us discover a new generation of precision medicines.
Industry: N/A
Domainempiri.co
Year Founded--
Employees51 - 200
Annual Revenue--
empiri.co
Empirico
Empirico (including company regionals)
  • empiri.co
    empiri.co
See more website traffic and engagement information

Total visits to Empirico's top domains

Understand Empirico market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Empirico's top domains

Analyze Empirico engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Empirico's top domains

See how Empirico keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.


Empirico top competitors by domain

Looks like there’s not enough data here

No Data to Display

Benchmark Your Digital Performance

Identify high-value opportunities, track your performance, and win your market.


Top technologies used by Empirico

These are the website technologies, by industry, used by Empirico top domains

Email Services (3)

G Suite

G Suite

Mobile (2)

Meta Viewport

Meta Viewport

Widget (2)

Twemoji

Twemoji

Business Solutions (1)

DocuSign

DocuSign

More Technologies

5

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.


News & Signals from Empirico

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsEmpirico Inc. is developing therapeutic antibodies resulting.Under the terms of the expanded agreement, Empirico would have the right to develop and commercialize therapeutic antibodies resulting from the collaboration, and AbCellera has the option to co-develop each therapeutic program to maintain up to a 50% ownership stake.
NewsEmpirico Inc. received financing of $10M in Series A2 on Jan 1st '20.As part of the deal, Ionis has taken a $10 million stake in Empirico, which also announced the close of a $17 million Series A-2 financing round.

See all Empirico signals

Focus your sales teams on the most promising opportunities. By prioritizing opportunities and engaging at the right time, you can optimize efforts and close more deals.